Morgan Stanley Raises CME Group (NASDAQ:CME) Price Target to $220.00

CME Group (NASDAQ:CME – Free Report) had its target price upped by Morgan Stanley from $215.00 to $220.00 in a research report report published on Thursday, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock. Several other research analysts have also recently commented on the company. Rosenblatt Securities reissued […]

Leave a Reply

Your email address will not be published.

Previous post Instant analysis from Ravens’ 31-24 win over Arizona Cardinals
Next post Maxeon Solar Technologies (NASDAQ:MAXN) & Broadcom (NASDAQ:AVGO) Critical Contrast